Company Filing History:
Years Active: 2004-2019
Title: Mary Newman: Innovator in Pharmaceutical Composition
Introduction
Mary Newman is a distinguished inventor based in Valrico, FL (US), known for her significant contributions to the field of pharmaceuticals. With a total of 5 patents, she has made remarkable strides in developing innovative treatments for various medical conditions.
Latest Patents
One of her latest patents is the formulation and use of exo-S-mecamylamine in treatment. This pharmaceutical composition includes a therapeutically effective amount of exo-S-mecamylamine or a pharmaceutically acceptable salt thereof, which is substantially free of exo-R-mecamylamine. The formulation is designed to treat a range of medical conditions, including substance addiction, smoking cessation, hypertension, Tourette's Syndrome, cancer, neuropsychiatric disorders, chronic fatigue syndrome, and more. The recommended dosage ranges from about 0.5 mg to about 20 mg, ensuring effective treatment for patients.
Career Highlights
Mary Newman is affiliated with the University of South Florida, where she continues her research and development in pharmaceutical sciences. Her work has garnered attention for its potential to address complex medical issues and improve patient outcomes.
Collaborations
Throughout her career, Mary has collaborated with notable colleagues, including Douglas Shytle and Paul R Sanberg. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.
Conclusion
Mary Newman exemplifies the spirit of innovation in the pharmaceutical industry. Her dedication to developing effective treatments showcases her commitment to improving health and well-being.